Effects of Caloric Intake on Intestinal Mucosal Morphology and Immune Cells in Rats Treated with 5-Fluorouracil by Murakami, Mariko et al.
74
Original Article J. Clin. Biochem. Nutr., 45, 74–81, July 2009
JCBN Journal of Clinical Biochemistry and Nutrition 0912-0009 1880-5086 the Society for Free Radical Research Japan Kyoto, Japan jcbn08-264 10.3164/jcbn.08-264 Original Article Effects of Caloric Intake on Intestinal Mucosal Morphology 
and Immune Cells in Rats Treated with 5-Fluorouracil
Mariko Murakami, Norifumi Sato*, Katsufumi Tashiro, Tsuyoshi Nakamura, 
and Hiroaki Masunaga
EN Otsuka Pharmaceutical Co., Ltd., R&D Laboratories, 4-3-5, Nimaibashi, Hanamaki, Iwate 025-0312, Japan
7 2009 30 6 2009 45 1 74 81 Received 16.12.2008 ; accepted 17.1.2009
*To whom correspondence should be addressed.
Tel: +81-198-30-1883 Fax: +81-198-30-1819
E-mail: n-sato@enotsuka.co.jp
Received 16 December, 2008; Accepted 17 January, 2009
Copyright © 2009 JCBN Summary Anticancer drugs have been reported to damage the intestinal mucosa. We
evaluated the effects of caloric intake on the mucosal morphology and immune cells in rats
treated with 5-fluorouracil (5-FU). Rats were received a liquid diet plus 5-FU treatment for 8
days as follows: Low calorie group (25 kcal/day with 5-FU), Normal calorie group (50 kcal/day
with 5-FU), and Control group (50 kcal/day with saline). The mucosal morphology, cell
numbers and phenotypes of spleen and intraepithelial lymphocytes (IEL) were assessed. As
compared with the control group, the villus heights were significantly lower in the Low calorie
group, but not significantly lower in the Normal calorie group. The total cell yield from the
spleen, CD4+ and CD8+ T cells decreased in the Low and Normal calorie group, but these
changes were less pronounced in Normal calorie group. The total cell yield from the IEL also
decreased in the Low calorie group, but not in the Normal calorie group. Our study
demonstrated that sufficient caloric intake attenuated the damages in intestinal morphology
and in the immune cell numbers. Clinically, nutritional support would be expected to be one
approach to reducing the risk of bacterial translocation or infection induced by chemotherapy.
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Introduction
Anticancer drugs have side effects such as gastrointestinal
injury, leucopenia, stomatitis and diarrhea, which sometimes
limit the chemotherapy, and influence the quality of life of
these patients [1, 2].
5-Fluorouracil (5-FU) is widely used on solid tumors [3].
It has been reported that the inhibition of DNA synthesis
caused by 5-FU injures the gastrointestinal tract mucosa [4],
and causes changes in intestinal mucosal morphology [5].
5-FU also injures immune cells of the host, thus causing
immunosuppression [6,  7]. These changes in mucosal
morphology and immune function might result in bacterial
translocation [5].
Many cancer patients are subjected to a reduced dietary
intake because of tumor-induced alterations in metabolism,
and/or treatment such as chemotherapy and radiation
therapy. Despite many advances in nutritional therapy, the
incidence of malnutrition remains high [8]. Reduced energy
intake causes the changes in mucosal morphology and gut
barrier function [9], or immune cell function [10–13].
Therefore, it appears that the reduced caloric intake could
deteriorate the 5-FU induced gastrointestinal injury. In this
study, we evaluated the effects of nutritional support on 5-
FU induced intestinal injury and immunosuppression. We
compared the effects of low and normal caloric intake on
mucosal morphology and immune cell numbers in rats
treated with 5-FU.Nutritional Support during Chemotherapy
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Materials and Methods
Animals
Male, 5 week-old Sprague-Dawley rats (CLEA Japan,
Inc., Tokyo) were housed in wire cages under controlled
temperature (23 ± 3°C) and humidity conditions (50 ± 20%),
with a 12-h light-dark cycle. The rats were fed commercial
laboratory chow, and were allowed drinking water ad
libitum for about one week before the surgery. The studies
reported herein conform to the guidelines for the care and
use of laboratory animals established by the Animal Use and
Care Committee of EN Otsuka Pharmaceutical Co., Ltd.
Surgical procedure for gastrostomy
After an overnight fast, the rats were anesthetized with
pentobarbital (45 mg/kg body weight, i.p.). A laparotomy
was performed through a midline incision. A catheter (5 Fr
size umbilical catheter, Nippon Sherwood Medical Ind.,
Tokyo) was then inserted into the stomach. The distal end of
the catheter was tunneled subcutaneously through the left
lateral abdominal wall, and exited at the interscapular
region. The catheter was attached to a swivel spring, which
allowed the rats freedom of movement in their individual
cages. After an overnight fast, the rats were fed chow and
were allowed drinking water ad libitum.
Experimental design
The experimental groups and design are outlined in
Table 1 and Fig. 1. The day before starting 5-FU treatment,
the rats were randomized into the three groups: Low calorie
group (n = 9) as a malnutrition model, Normal calorie group
(n = 10) as a nutritional support model and Control group
(n = 10). The rats received 25 kcal/day (Low calorie group),
or 50 kcal/day (Normal calorie and Control groups) of
liquid diet. The calorie administration of 25 kcal/day of
liquid diet was based on the amount that the rats fed ad
libitum during the 5-FU treatment (data not shown). The
composition of the liquid diet (Racol®, EN Otsuka Pharma-
ceutical Co., Ltd, Iwate) is shown in Table 2. The liquid diet
was given by an infusion pump for 16 h. The rats in the Low
calorie and Normal calorie groups were treated with 5-FU
(20 mg/kg, i.p.), and the rats in the Control group were
treated with an equal volume of saline for 8 consecutive
days. On day 8, rats were sacrificed, and the spleen was
excised for spleen cell isolation from five rats in each group.
The intestinal mucosal morphology was also observed in the
same rats. The small intestine was excised for intraepithelial
lymphocyte (IEL) isolation from the remaining rats.
Intestinal mucosal morphology
Duodenum samples were taken at 5 cm before the ligament
of Treitz, and jejunum samples were taken at 10 cm after
the ligament of Treitz. The wet weight of intestinal samples
were weighed, and expressed as mg/cm. The proximal 2 cm
segment was cut off, and opened longitudinally along the
mesenteric side. The serosal side of the intestine was placed
on paper for orientation, and then inserted into a 10%
buffered formalin solution. The samples were embedded in
paraffin, cut 5 μm thick, and strained with hematoxylin and
eosin. The villus heights of the duodenum and jejunum
were measured using an ocular micrometer under light
microscopy. Ten visual fields from each specimen were
measured, and the average value was taken.
Cell isolation
The spleen and small intestine were placed in tissue
culture medium RPMI 1640 (Nissui Pharmaceutical, Tokyo,
Japan) containing 10% fetal bovine serum (FBS), 2 mM
glutamine, 100 g/liter streptomycin, and 100,000 IU/liter
penicillin. The spleen was then passed through a sterile
wire mesh to remove any tissue debris. After centrifugation,
the pellets were incubated with 0.83% NH4Cl Tris buffer for
10 min to lyse the red blood cells. The cells were washed
twice, and resuspended in tissue culture media.
The IEL were isolated by using the method reported
previously [14]. After removing the small intestine, it was
placed in Hank’s balanced salt solution (HBSS, Gibco,
Table 1. Experimental groups
Groups
Administration of 
liquid diet
Injection of 5-FU 
(20 mg/kg/day)
Control 50 kcal/day −
Low calorie 25 kcal/day +
Normal calorie 50 kcal/day +
Fig. 1. Experimental design. After a gastrostomy, rats were
received a liquid diet plus 5-FU treatment for 8 days as
follows: Low calorie group (25 kcal/day with 5-FU
treatment), Normal calorie group (50 kcal/day with 5-FU
treatment), and Control group (50 kcal/day with saline).
The calorie administration of 25 kcal/day of liquid diet
was based on the amount that the rats fed ad libitum
during the 5-FU treatment (data not shown). The liquid
diet was given by an infusion pump for 16 h.M. Murakami et al.
J. Clin. Biochem. Nutr.
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GrandIsland, NY.) containing 5% FBS. The intestine was
turned inside out, cut into 2 cm pieces and incubated with
HBSS (Ca, Mg-free, 5% FBS, 5 mM EDTA) for 45 min at
37°C in a water shaker (150 rpm). The supernatants were
then filtered through a glass wool column. After centrifuga-
tion, the pellets were suspended in 44% Percoll (Amersham
Bioscience AB, Uppsala, Sweden), and the cell suspensions
were overlaid onto 70% Percoll. After centrifugation for
20 min at 600 g at 20°C, the lymphocytes were recovered
from the 44/70% interface and washed in tissue culture
media. The lymphocytes were finally resuspended in tissue
culture medium as described above.
Flow cytometry
Fluorescein isothiocyanate (FITC)-conjugated anti-rat
CD4, CD8, TCRαβ and TCRγδ antibodies were obtained
from BioLegend (San Diego, CA). CD4 and CD8 were used
as general markers of T cell subsets. TCRαβ and TCRγδ
were used to identify the αβ chain T-cell receptor and the γδ
chain T-cell receptor of IEL, respectively. To determine the
phenotypes of the lymphocyte, spleen cells and IEL
(2 × 105 cells/100 μL) were incubated with monoclonal
antibodies (10 μL) for 30 min in the dark on ice. The cells
were washed twice with ice-cold PBS/1% FBS, and the
antigen expressions were then analyzed with a flow cyto-
meter FC500 (Coulter, Miami, FL).
Statistical analysis
The results were expressed as means ± SD. The statistical
analysis was performed by Tukey-Kramer’s HSD test and
p values less than 0.05 were considered to be statistically
significant.
Results
Body weight
Before 5-FU treatment (On day-1), there were no signifi-
cant differences in body weight among the three groups
(Control group: 224.7 ± 13.2 g, Low calorie group:
228.6 ± 10.0 g, and Normal calorie group: 227.0 ± 11.0 g).
On day 8, body weight of the Low calorie group
(182.7 ± 9.8 g) was lower than that of the Control and
Normal calorie groups (231.4 ± 10.8 and 231.1 ± 8.2 g,
respectively). In the Control and Normal calorie groups, the
body weight was maintained during the experimental period,
and there was no significant difference in body weight
between these two groups (Fig. 2).
Intestinal mucosal morphology
The wet weights of both the duodenum and jejunum in the
Low calorie group were lower than those of the Control
group, but there were no statistically significant differences.
The wet weight of the duodenum in the Normal calorie
group was higher than that of the Low calorie group. The
villus heights in both the duodenum and jejunum in the Low
calorie group were lower than in the Control group (Table 2
and Fig. 3). There were no significant differences in villus
height between the Control and Normal calorie groups. All
rats in the three groups didn’t have diarrhea during the
experimental period.
Total cell yield
The number of cells isolated from the spleen and IEL
were significantly decreased in the Low calorie group as
compared with the Control group (Fig. 4). In the Normal
calorie group, the number of spleen cells was significantly
decreased as compared with the Control group, but signifi-
cantly higher than the Low calorie group. There was no
significant difference in the number of IEL between the
Control and Normal calorie group.
Table 2. Composition of liquid diet (per 100 kcal, 100 mL)
Ingredient Contents Unit
Protein 4.38 g
Fat 2.23 g
Carbohydrate 15.62 g
Minerals
Sodium 73.8 mg
Potassium 138 mg
Calcium 44 mg
Magnesium 19.3 mg
Phosphorus 44 mg
Chloride 117 mg
Iron 625 μg
Zinc 640 μg
Manganese 133 μg
Copper 125 μg
Vitamins
Retinol palmitate 207 IU
Cholecalciferol 13.6 IU
Tocopherol acetate 650 μg
Phytonadione 62.5 μg
Thiamine 380 μg
Riboflavin 245 μg
Pyridoxine 375 μg
Cyanocobalamin 0.32 μg
Ascorbic acid 25 mg
Nicotinamide 2.5 mg
Pantotheic acid 958 μg
Folic acid 37.5 μg
Biotin 3.86 μgNutritional Support during Chemotherapy
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Lymphocyte phenotypes
The percentage of CD4+ T cells in the spleen in the Low
calorie group was significantly higher than in the Control
group (Table 3). There were no significant differences in
the percentages of CD8+ T cell in the spleen and IEL
phenotypes between the Low calorie group and the Control
group. There were no significant differences in lymphocyte
phenotypes in the spleen and IEL between the Control and
Normal calorie groups.
The absolute numbers of CD4+ and CD8+ T cells in the
spleen in both Low calorie group and Normal calorie groups
were significantly decreased as compared with the Control
group (Table 4). In the Normal calorie group, the absolute
numbers of CD4+ and CD8+ T cells in the spleen were
significantly increased as compared with the Low calorie
group. The absolute numbers of IEL phenotypes in the
Normal calorie group was closer to the numbers from the
Control group than the Low calorie group, whereas the
numbers from the Low group tended to belower than the
Normal and Control groups.
Discussion
The present study demonstrated the effects of different
levels of caloric intake on the mucosal morphology and
immune cells in rats treated with 5-FU. Although 5-FU is
known to influence mucosal morphology and immune func-
tion, the effects of the caloric intake on these changes has
not been previously well characterized. Our data indicate
that the combination of reduced energy intake and 5-FU
treatment results in significant atrophy of the mucosa and
changes in systemic and mucosal immunity. These changes
can be minimized or eliminated when sufficient nutrients
are administered enterally.
The intestinal mucosa is the barrier created by the physical
structure of the epithelium. In addition, the gut-associated
Fig. 2. Effect of caloric intake on the body weight of 5-FU
treated rats. The data represent the body weight of
Control group (open circles; n = 10), Low calorie group
(closed squares; n = 9) and Normal calorie group (closed
circles; n = 10). After a gastrostomy, rats were received a
liquid diet plus 5-FU treatment for 8 days as follows:
Low calorie group (25 kcal/day with 5-FU treatment),
Normal calorie group (50 kcal/day with 5-FU treatment),
and Control group (50 kcal/day with saline). Significant
differences between Low calorie group and Normal
calorie group were observed after day 1. Values are
means ± SD. *p<0.05 represents statistical differences
compared with Control group; †p<0.05 represents
statistical differences compared with the Normal calorie
group; Data were analyzed by using Tukey-Kramer’s
HSD test.
Fig. 3. Structure of jejunum. (A)Control group, (B) Low calorie group, and (C) Normal calorie group. Rats were received a liquid diet
plus 5-FU or saline treatment from day 0 to day 7. On day 8, rats were sacrificed. The duodenum and jejunum tissues were
removed from five rats per group. Each sample was processed for hematoxylin and eosin staining as described in Material and
methods.M. Murakami et al.
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Table 3. Effects of caloric intake on the intestinal mucosal morphology.
The 5-FU induced low caloric intake decreased the villus height in duodenum and jejunum. Sufficient caloric intake attenuated these
changes in intestinal morphology. Values are means ± SD. *p<0.05 represents statistical differences compared with Control group;
†p<0.05 represents statistical differences compared with the Normal calorie group; Data were analyzed by using Tukey-Kramer’s
HSD test.
Groups
duodenum jejunum
Wet weight (mg/cm) Villus height (μm) Wet weight (mg/cm) Villus height (μm)
Control 112.4 ± 25.4 466 ± 36 83.1 ± 19.1 519 ± 52
Low calorie 84.8 ± 6.3† 362 ± 38* 70.1 ± 11.4 339 ± 72*
Normal calorie 116.4 ± 17.3 407 ± 88 91.7 ± 28.3 420 ± 118
Table 4. Changes in the absolute numbers of lymphocyte subsets in the spleen and IEL.
Spleen cells and intraepithelial lymphocytes (IEL) were isolated on day 8, and the antigen expressions were then analyzed with a flow
cytometer. The 5-FU induced low caloric intake decreased the CD4+ and CD8+ cell numbers in spleen. Values are means ± SD.*p<0.05
represents statistical differences compared with Control group; †p<0.05 represents statistical differences compared with the Normal
calorie group; Data were analyzed by using Tukey-Kramer’s HSD test.
Groups
Spleen (×107)I E L  ( ×105)
CD4+ CD8+ CD4+ CD8+ TCRαβ+ TCRγδ+
Control 13.0 ± 1.7 4.7 ± 0.9 2.2 ± 1.2 20.4 ± 12.8 18.3 ± 8.8 3.1 ± 2.1
Low calorie 5.3 ± 0.9*† 1.3 ± 0.5*† 0.9 ± 0.6 8.2 ± 4.1 9.4 ± 4.7 1.2 ± 0.4
Normal calorie 8.3 ± 1.4* 2.7 ± 0.6* 1.9 ± 0.8 21.2 ± 11.4 18.4 ± 9.5 3.3 ± 1.8
Fig. 4. Effect of caloric intake on total cell yield from spleen (A) and intraepithelial lymphocytes (B). Rats were received a liquid diet
plus 5-FU or saline treatment from day 0 to day 7. On day 8, rats were sacrificed. The spleen cells were isolate from five rats per
group and intraepithelial lymphocytes were isolated from five rats (Normal calorie and Control group) or four rats (Low calorie
group). The 5-FU induced low caloric intake decreased the immune cell numbers. Values are means ± SD. *p<0.05 represents
statistical differences compared with Control group; †p<0.05 represents statistical differences compared with the Normal calorie
group; Data were analyzed by using Tukey-Kramer’s HSD test.Nutritional Support during Chemotherapy
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lymphoid tissue (GALT) is an immunologic barrier in the
intestine. Bacterial translocation is promoted by: (i) physical
disruption of the mucosal barrier, (ii) intestinal bacterial
overgrowth, or (iii) suppression of the host immune defenses
[15]. Under stressed conditions, indigenous bacteria can
pass through the epithelial cells, enter the lamina propria,
and appear in the mesenteric lymph nodes (MLN). From
the MLN, these bacteria may spread to other sites, such as
the liver, spleen, kidneys, and blood [16]. Bacterial trans-
location causes sepsis-like manifestations after cancer
chemotherapy [5]. Therefore, preventing bacterial trans-
location during chemotherapy is important for cancer patients.
In the current study, the decreases in the villus height
correlated with the magnitude of caloric intake with 5-FU
treatment. In the clinical field, diarrhea is one of the impor-
tant side effects of 5-FU. It has been reported that the degree
of diarrhea was well correlated with the histological changes
of the gastrointestinal mucosa [5]. In our study, we observed
that all rats treated with 5-FU didn’t have diarrhea, although
mucosal damage was caused by 5-FU. We administered
5-FU at 20 mg/kg for rats, that dose might be relatively
small dose to examine the effect to diarrhea. Under this
condition, it is also possible that the changes in the mucosal
morphology might be due to a loss of nutritional substrates
and hormonal stimulation [17–19]. With respect to the
mechanisms of the loss of villus length, dietary restriction
reportedly results in decreased epithelial cell proliferation
and increased apoptosis [9]. The maintenance of gut
mucosal homeostasis depends on a balance between cell
proliferation and cell death. Anticancer drugs might increase
mucosal epithelial cell apoptosis because of the rapid
turnover of the cells. Therefore, chemotherapy and reduced
energy intake might worsen the overall mucosal morphology.
Reduced energy intake and 5-FU treatment also caused a
loss of the total cell yield in the spleen and IEL, suggesting
an impairment of the immunologic barrier. The absolute
numbers of CD4+ and CD8+ T cells in the spleen were
preserved by sufficient caloric intake. CD4+ and CD8+ T
cells in the IEL tended to be preserved by sufficient caloric
intake, but, there were no statistically significant differ-
ences. IEL is one of the major effector components in the
GALT, and produces various cytokines such as interferon
(IFN)-γ, IL-10, transforming growth factor-beta (TGF-β),
and regulates the immune response to foreign antigens. Any
depletion of the CD4+ and CD8+ T cells within the GALT
could increase bacterial translocation [15, 20].
In clinical practice, parenteral nutrition (PN) is often
chosen for nutritional support. However, PN induces
mucosal villus atrophy, epithelial cell apoptosis, and
bacterial translocation in the mouse model [21, 22]. Sun
et al. reported that the lack of enteral nutrition, rather than
absolute caloric levels, is responsible for many of the
adverse effects of PN [22]. They reported that PN-associated
epithelial derangements were worsened by reducing the
caloric PN delivery, and even with full caloric delivery,
the mucosal morphology and function are compromised in
comparison to the control state (enteral nutrition). Therefore,
PN during the chemotherapy might lead to more adverse
changes of the mucosal morphology and gut barrier func-
tion. PN administration also results in phenotypic and
functional changes in the GALT [23, 24]. PN feeding in
mice resulted in atrophy of the GALT and T-cell and B-cell
populations, and decreased in intestinal IgA levels [24].
Cytokine mRNA levels in the IEL were also decreased by
PN [23]. These mucosal immune changes might account for
the elevation in bacterial translocation. Enteral nutrition
during chemotherapy would be effective to maintain the
mucosal barrier function.
The patient’s nutritional status affects the toxicity of
chemotherapy. Host toxicity such as leucopenia and diarrhea
caused by 5-FU was increased by protein energy malnutri-
tion [25]. With respect to the mechanism responsible for this
phenomenon, the metabolism rate of 5-FU is implicated
[26]. Protein depletion results in a decreased rate of hepatic
metabolism and clearance of 5-FU, and decreased activity of
hepatic dihydropyrimidine dehydrogenase (DPD) which
deactivates 5-FU [27]. Thus, nutritional support is important
for tissue regeneration and drug metabolism.
Recently, certain nutrients have been shown to be bene-
ficial during cancer chemotherapy. In our present study, we
used the enteral nutrition enriched with soybean as a protein
source and omega-3 fatty acids as a fat source. Mitsugi et al.
reported the protective effect of the enteral diet containing
soybean protein and omega-3 fatty acid from severe diarrhea
and death caused by methotrexate [28]. Soybean containing
diet has been shown to protect animals from methotrexate-
induced anorexia and diarrhea when compared with casein
[29]. Moreover, omega-3 fatty acid has been shown to
reduce the gastrointestinal, hematological or cardiac side
effects of various chemotherapeutic treatments [30,  31].
Thus, the supplementation of these nutrients during nutri-
tional support could contribute to attenuate the mucosal
injury as well as caloric intake. Further studies are needed
on the effect of these nutrients on the mucosal injury by 5-
FU chemotherapy.
In summary, reduced energy intake during 5-FU treatment
resulted in significant atrophy of the intestinal mucosa, and
a decrease in the numbers of systemic and mucosal immune
cells. Preservation of the mucosal morphology and immune
cells with sufficient energy intake might result in an
increased resistance to infection. Clinically, nutritional
support during chemotherapy could be one approach to
reducing the risk of anticancer drugs induced bacterial
translocation or infection.M. Murakami et al.
J. Clin. Biochem. Nutr.
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